Back to search
Relapsing or Refractory Multiple Sclerosis (MS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsing or Refractory Multiple Sclerosis (MS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsing or Refractory Multiple Sclerosis (MS) trials you may qualify forThis trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolera…
This single-arm, open-label investigator-initiated trial (IIT) evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-05 i…